You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • OP0267 Initial Combination Therapy of Ambrisentan and Tadalafil in Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH): Subgroup Analysis from the Ambition Trial

Article metrics

Article menu
Download PDFPDF
Oral Presentations
Are we ready for RCTs in scleroderma? Importance of disease stratification and application of predictive markers
OP0267 Initial Combination Therapy of Ambrisentan and Tadalafil in Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH): Subgroup Analysis from the Ambition Trial

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 20152905
Jul 20156403
Aug 201553010
Sep 20155704
Oct 20153703
Nov 20156405
Dec 20155104
Jan 201662011
Feb 20163706
Mar 20165109
Apr 20164208
May 20163503
Jun 20166413
Jul 20162401
Aug 20164305
Sep 20162601
Oct 20163600
Nov 20165106
Dec 20162201
Jan 201748024
Feb 20172603
Mar 20171401
Apr 2017801
May 20171100
Jun 20171600
Jul 20171602
Aug 20171200
Sep 20172400
Oct 20174603
Nov 20176000
Dec 20177800
Jan 20187400
Feb 20183601
Mar 20183600
Apr 20187800
May 20182000
Jun 20181600
Jul 20182200
Aug 2018400
Oct 20181400
Nov 20181600
Dec 20181601
Jan 20192300
Feb 2019800
Mar 2019400
Apr 2019601
May 2019800
Jun 2019400
Jul 20191502
Aug 2019200
Sep 2019800
Oct 2019600
Nov 2019600
Dec 2019600
Feb 2020601
Mar 2020200
Apr 2020400
May 2020800
Jun 20201200
Jul 20201600
Aug 2020800
Sep 20201600
Oct 2020200
Nov 2020601
Dec 20202600
Jan 2021800
Feb 20211002
Mar 20211000
Apr 20212000
May 2021400
Aug 2021200
Sep 2021100
Oct 2021600
Nov 20211600
Dec 20211400
Jan 20223500
Feb 2022600
Mar 20221300
Apr 2022700
May 20221000
Jun 2022500
Jul 20221800
Aug 20221900
Sep 20221400
Oct 2022500
Nov 2022800
Dec 20221300
Jan 20231000
Feb 2023400
Mar 2023200
Apr 2023300
May 2023500
Jun 2023300
Jul 2023200
Aug 2023900
Sep 20232801
Oct 2023400
Dec 2023900
Jan 20241100
Feb 2024800
Mar 2024402
Total20871134